L-arginine-nitric oxide pathway-related metabolites in the aqueous humor of diabetic patients

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 1, 2000, Pages 213-217

  Hattenbach, Lars Olof ^a   Allers, Agnieszka ^a   Klais, Christina ^a   Koch, Frank ^a   Hecker, Markus ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Klin Johann Wolfgang Goethe Univ ^*

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; N(G) HYDROXYARGININE; NITRIC OXIDE;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PRIORITY JOURNAL; RETINA BLOOD FLOW; SIGNAL TRANSDUCTION;

AGED; AGED, 80 AND OVER; AQUEOUS HUMOR; ARGININE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CITRULLINE; DIABETIC RETINOPATHY; HUMANS; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; UP-REGULATION;

EID: 0033986071     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Veriac S, Tissie G, Bonne C. Oxygen free radicals adversely affect the regulation of vascular tone by nitric oxide in rabbit retina under high intraocular pressure. Exp Eye Res. 1993;56:85-88.
2. Wiederholt M, Sturm A, Lepple-Wienhues A. Relaxation of trabecular meshwork and ciliary muscle by release of nitric oxide. Invest Ophthalmol Vis Sci. 1994;35:2515-2520.
3. Goureau O, Lepoivre M, Becquet F, Courtois Y. Differential regulation of inducible nitric oxide synthase by fibroblast growth factors and transforming growth factor β in bovine retinal pigmented epithelial cells: inverse correlation with cellular proliferation. Proc Natl Acad Sci USA. 1993;90:4276-4280.
4. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43: 109-142.
5. D'Amore P. Mechanisms of retinal and choroidal neovascularization. Invest Ophthalmol Vis Sci. 1994;35:3974-3979.
6. Chaudhury AR, Frischer H, Malik AB. Inhibition of endothelial cell proliferation and bFGF-induced phenotypic modulation by nitric oxide. J Cell Biochem. 1996;63:125-134.
7. Tilton RG, Chang K, Hasan KS, et al. Prevention of diabetic vascular dysfunction by guanidines: inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 1993; 42:221-232.
8. G-hydroxy-L-arginine in alveolar macrophages: implications for the utilization of L-arginine for nitric oxide synthesis. FEBS Lett. 1995;359:251-254.
9. Meyer J, Richter N, Hecker M. High-performance liquid chromatography determination of nitric oxide synthase-related arginine derivatives. Anal Biochem. 1997;246:1-6.
10. Hecker M, Sessa WC, Harris HJ, Änggard EE, Vane JR. The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine. Proc Natl Acad Sci. USA. 1990;87: 8612-8616.
11. Chakravarthy U, Stitt AW, McNally J, Bailie JR, Hoey EM, Duprex P. Nitric oxide synthase activity and expression in retinal capillary endothelial cells and pericytes. Curr Eye Res 1995;14:285-294.
12. Jacot JL, O'Neill JT, Scandling DM, West SD, McKenzie JE. Nitric oxide modulation of retinal, choroidal, and anterior uveal blood flow in newborn piglets. J Ocul Pharmacol Ther. 1998;14:473-489.
13. Schmetterer L, Findl O, Fasching P. et al. Nitric oxide and ocular blood flow in patients with IDDM. Diabetes. 1997;46:653-658.
14. Adachi K, Kashii S, Masai H. et al. Mechanism of the pathogenesis of glutamate neurotoxicity in retinal ischemia. Graefes Arch Clin Exp Ophthalmol. 1998;236:766-774.
15. Kikuchi M, Kashii S, Mandai M, et al. Protective effects of FK506 against glutamate-induced neurotoxicity in retinal cell culture Invest Ophthalmol Vis Sci. 1998;39:1227-1232.
16. Frank RN, Amin RH, Eliot D, Puklin JE, Abra,s GW. Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. Am J Ophthalmol. 1996;122:393-403.